Seemai Desai, MD, FAAD, a dermatologist in private and academic practice in Dallas, Texas, discusses the development and use of JAK inhibitors for inflammatory skin diseases, such as atopic dermatitis, and reviews the newly approved oral and topical JAK inhibitors for AD. Dr. Desai goes on to discuss the benefits he’s observed when treating his patients with these new agents.
Dr. Silverberg discusses how to safely counsel patients when deciding...
